Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Interventional Radiology(Electronic Edition) ›› 2016, Vol. 04 ›› Issue (02): 109-114. doi: 10.3877/cma.j.issn.2095-5782.2016.02.012

Special Issue:

• Research ProjectProtocal • Previous Articles     Next Articles

Cerebrovascular drug-eluting stents verse bare metal stents in the treatment of vertebral artery stenosis

Yingkun He1, Tianxiao Li1,(), Weixing Bai1, Liangfu Zhu1, Ziliang Wang1, Jiangyu Xue1, Guang Feng1, Zhouqin Feng1, Meiyun Wang2, Li Li1, Zhaoshuo Li1, Tongyuan Zhao1, Bin Xu1, You Zhang3, Yongmei Tian4, Yan Bai2, Xiaojuan Zhao5, Xiaodong Liang1, Qiuji Shao1, Kaitao Chang1, ZhenZhen Li1   

  1. 1. Interventional Department of Zhengzhou University People’s Hospital and Cerebrovascular Center of Henan Provincial People’s Hospital
    2. Radiology Department of Zhengzhou University People’s Hospital
    3. Epidemiology Center of Zhengzhou University People’s Hospital
    4. Ultrasound Department of Henan Provincial People’s Hospital
    5. Ultrasound Department of Zhengzhou University People's Hospital, Zhengzhou 450003, China
  • Received:2016-04-20 Online:2016-05-01 Published:2016-05-01
  • Contact: Tianxiao Li
  • About author:
    Corresponding author: Li Tianxiao, Email:

Abstract:

Objective:

To evaluate the safety and efficacy of the new drug-eluting stent in the treatment of vertebral artery stenosis.

Methods:

This study was a single-center, randomized controlled trial of pre-marketing I-II stage. 40 patients with the severe stenosis of the vertebral artery (≥70% stenosis) were enrolled in this study. All the patients were divided into experimental group and control group according to the ratio of 1: 1. In the experimental group, a new cerebrovascular drug-eluting stent system (MauroraStent) was used. In the control group, a bare metal stent (Apollo) was used. The primary outcomes were surgical-related complications within 30 days and in-stent restenosis on the 6 months after surgery. Secondary outcomes were as follows : ipsilateral transient ischemic attack, stroke, death, As well as all adverse events and serious adverse events.

Results:

Enrollment began in September 2014, and was done in september 2015 with 40 patients enrolled into the study. 12-month data including ipsilateral complication, transient ischemic attack, stroke and all adverse events were collected. Data entry and analysis are ongoing.

Conclusions:

This study will provide a clinical basis for the clinical application of drug-eluting stent in cerebrovascular disease, and provide reference for the later phase Ⅲ multicenter randomized controlled study.

Key words: Vertebral artery stenosis, Drug-eluting stent, Bare metal stent, Randomized controlled trial

京ICP 备07035254号-20
Copyright © Chinese Journal of Interventional Radiology(Electronic Edition), All Rights Reserved.
Tel: 0756-2528259 E-mail: zhjrfsx@163.com
Powered by Beijing Magtech Co. Ltd